News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
The One Simple Reason Investors Should Still Steer Clear Away From Valeant
August 25, 2017
·
1 min read
Deals
Debt-Ridden Valeant Dumps Another Asset in $190 Million Cash Deal
July 17, 2017
·
3 min read
Deals
Valeant: Was iNova Pharma Sale The Worst Deal Ever?
June 19, 2017
·
1 min read
Business
The Not-So-Subtle Reason Behind Valeant’ 30% Rise In May
June 8, 2017
·
1 min read
Deals
Debt-Ridden Valeant Nears Sale of Its $2 Billion Eye Care Biz Bausch & Lomb
June 7, 2017
·
2 min read
68 Hedge Funds Buy Valeant For The First Time
May 31, 2017
·
1 min read
Policy
Why Valeant CEO Thinks Johnson & Johnson Should Foot The Bill For Their Talc Defense
May 25, 2017
·
1 min read
Genetown
Short Seller Who Unraveled Valeant Zeroes in On This Massachusetts Biotech
May 16, 2017
·
2 min read
Is This The Real Reason Valeant’s Shares Are Skyrocketing?
May 12, 2017
·
1 min read
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
·
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
·
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
·
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
·
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
·
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
·
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
·
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
·
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
·
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
·
4 min read